Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD15 antigen, also known as Lewis x (Le^x), X-hapten, or stage-specific embryonic antigen-1 (SSEA-1), is a carbohydrate epitope with the structure 3-fucosyl-N-acetyllactosamine. This trisaccharide determinant is present on various glycolipids and glycoproteins at the cell membrane. It plays roles in immune functions like phagocytosis, chemotaxis, and leukocyte trafficking. Clinically, it is primarily used as a diagnostic marker for Hodgkin lymphoma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD15 Antigen (CD15).